ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,977.88
0.14%
S&P 500
5,127.79
1.26%
Dow Jones
38,675.68
1.18%
US Dollar vs Yen
153.055
0.01%
Brent Oil
82.765
0.00%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Nymox Pharmaceutical Corp (NYMX)

  7. Nymox Pharmaceutical Corp (NYMX) ニュース

NYMX

Nymox Pharmaceutical (NYMX)

Nymox Pharmaceutical Corp
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:NYMX
日付受信時刻ニュースソース見出しコード企業名
2024/03/2902 : 03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
2023/11/1002 : 55Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
2023/11/0623 : 59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
2023/10/2704 : 31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
2023/09/0823 : 13Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NYMXNymox Pharmaceutical Corp
2023/08/3004 : 34Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
2023/08/0302 : 40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
2023/08/0102 : 54Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
2023/07/2605 : 04Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
2023/07/2605 : 02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
2023/07/2523 : 33GlobeNewswire Inc.Nymox Reports Successful New NYMOZARFEX (TM) Long-Term Prostate Cancer Treatment Clinical Trial ResultsNASDAQ:NYMXNymox Pharmaceutical Corp
2023/07/1823 : 45GlobeNewswire Inc.Nymox Reports on U.S. Patent IssuancesNASDAQ:NYMXNymox Pharmaceutical Corp
2023/07/1323 : 16GlobeNewswire Inc.Nymox UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
2023/07/1306 : 08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
2023/07/1222 : 30GlobeNewswire Inc.Nymox Announces Appointment Of Patrick Doody as Vice President and Member of the Board of Directors of NymoxNASDAQ:NYMXNymox Pharmaceutical Corp
2023/07/0806 : 02GlobeNewswire Inc.NYMOX UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
2023/07/0607 : 11GlobeNewswire Inc.Nymox Delisting from NASDAQNASDAQ:NYMXNymox Pharmaceutical Corp
2023/06/3006 : 15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NYMXNymox Pharmaceutical Corp
2023/06/3006 : 15Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:NYMXNymox Pharmaceutical Corp
2023/06/3005 : 25Edgar (US Regulatory)Amended Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k/a)NASDAQ:NYMXNymox Pharmaceutical Corp
2023/06/3005 : 24Edgar (US Regulatory)Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]NASDAQ:NYMXNymox Pharmaceutical Corp
2023/06/2806 : 15Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NYMXNymox Pharmaceutical Corp
2023/06/2623 : 28Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:NYMXNymox Pharmaceutical Corp
2023/05/1905 : 14Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:NYMXNymox Pharmaceutical Corp
2023/05/1305 : 53Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:NYMXNymox Pharmaceutical Corp
2023/05/1023 : 00GlobeNewswire Inc.Nymox Provides Current UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
2023/04/0322 : 30GlobeNewswire Inc.Nymox Provides Corporate UpdateNASDAQ:NYMXNymox Pharmaceutical Corp
2023/04/0105 : 25Edgar (US Regulatory)Notification That Form 20-f Will Be Submitted Late (nt 20-f)NASDAQ:NYMXNymox Pharmaceutical Corp
2023/03/2123 : 00GlobeNewswire Inc.Nymox Announces Appointment of Christopher R. Riley as Chief Financial OfficerNASDAQ:NYMXNymox Pharmaceutical Corp
2023/03/1522 : 30GlobeNewswire Inc.Nymox Officially Granted Extension to Regain Listing RequirementsNASDAQ:NYMXNymox Pharmaceutical Corp
 Showing the most relevant articles for your search:NASDAQ:NYMX

最近閲覧した銘柄

AMEX
XLV
Health Care Select Sector
NYSE
KO
Coca Cola
FX
USDJPY
US Dollar vs Yen
NASDAQ
TSLA
Tesla
USOTC
DTEGY
Deutsche Telekom (QX)
USOTC
RHHBY
Roche (QX)
NYSE
NKE
Nike
CCOM
SILVER
SILVER
NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
MRK
Merck
CCOM
US30
US 30
FX
USDGBP
US Dollar vs Sterling
NYSE
XOM
Exxon Mobil
CCOM
US500
US 500
NYSE
MCD
McDonalds
AMEX
XLE
Energy Select Sector SPDR
Delayed Upgrade Clock
ADVFN Logo

日本
会社情報
ビジネス
人気
アプリを入手

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有